<p>在 12 月 17 日，<strong>MARK ORDAN</strong>，<strong>Pediatrix Medical Group</strong>（紐約證券交易所代碼：MD）的首席執行官，報告了一筆大規模的內部出售，基於最近的 SEC 文件。</p>
<p>** 發生了什麼：**ORDAN 最近的舉動涉及出售 23,000 股 <strong>Pediatrix Medical Group</strong> 的股票。這一信息在週三的美國證券交易委員會的 Form 4 文件中有記錄。總價值為 515,430 美元。</p>
<p>在週四的早盤交易中，<strong>Pediatrix Medical Group</strong> 的股票下跌了 0.27%，目前價格為 22.5 美元。</p>
<h3>瞭解 Pediatrix Medical Group：更深入的觀察</h3>
<p>Pediatrix Medical Group Inc 為醫院、重症監護室和其他醫療單位提供醫生服務。該公司提供的服務包括為孕婦提供母嬰護理、為早產兒提供重症監護、為患有心臟缺陷的嬰兒提供心臟病護理，以及在手術期間提供麻醉護理等。該公司僅在一個部門運營，提供包括新生兒、母胎和其他兒科專業護理的醫生服務。它的收入主要來自新生兒學和其他兒科專業。</p>
<h3>財務洞察：Pediatrix Medical Group</h3>
<p><strong>收入挑戰：</strong> 截至 2025 年 9 月 30 日，Pediatrix Medical Group 的收入增長面臨困難。公司經歷了約 <strong>-3.58%</strong> 的下降。這表明其收入出現了下滑。與競爭對手相比，該公司的增長率低於醫療保健行業的平均水平。</p>
<p><strong>分析盈利能力指標：</strong></p>
<ul>
<li>毛利率：該公司的毛利率為 28.48%，在成本效率和盈利能力方面優於行業同行。</li>
</ul>
<ul>
<li>每股收益（EPS）：Pediatrix Medical Group 的每股收益超出行業平均水平，當前每股收益為 0.85，顯示出強勁的盈利趨勢。</li>
</ul>
<p>** 債務管理：**Pediatrix Medical Group 的債務與股本比率低於行業標準，表明其財務結構穩健，比例為 <strong>0.72</strong>。</p>
<p><strong>估值指標：</strong></p>
<ul>
<li>市盈率（P/E）：Pediatrix Medical Group 的市盈率為 11.81，低於行業平均水平，暗示該股票可能被低估。</li>
</ul>
<ul>
<li>市銷率（P/S）：市銷率為 1.0，低於行業平均水平。這表明基於銷售表現可能存在低估。</li>
</ul>
<ul>
<li>企業價值/息税折舊攤銷前利潤（EV/EBITDA）分析：該公司的 EV/EBITDA 比率為 8.01，低於行業平均水平，暗示可能被低估，這對價值投資者可能是有利的。</li>
</ul>
<p><strong>市值分析：</strong> 該公司的市值低於行業基準，反映出相對於同行的規模較小。這可能與增長預期或運營能力等因素有關。</p>
<p>現在通過查爾斯·施瓦布在線免佣金交易股票，這是一個值得信賴的全面投資公司。</p>
<h3>揭示內部活動的重要性</h3>
<p>投資者應將內部交易視為多方面分析的一部分，而不是僅僅依賴於它們進行決策。</p>
<p>在法律術語中，“內部人” 是指任何公司股權證券的官員、董事或持有超過 10% 權益的受益所有者，這些證券根據 1934 年證券交易法第 12 條註冊。這可以包括高管和大型對沖基金。這些內部人需要通過 Form 4 文件向公眾披露他們的交易，該文件必須在交易後的兩個工作日內提交。</p>
<p>當公司內部人進行新購買時，這表明他們預計股票將會上漲。</p>
<p>另一方面，內部出售可能出於多種原因，並不一定意味着賣方認為股票會下跌。</p>
<h3>值得關注的交易代碼</h3>
<p>在審查交易時，投資者 通常集中於在公開市場上進行的交易，這些交易在 Form 4 文件的表格 I 中詳細列出。Box 3 中的 <strong>P</strong> 表示購買，而 <strong>S</strong> 表示出售。交易代碼 <strong>C</strong> 表示期權的轉換，交易代碼 <strong>A</strong> 表示從公司獲得的證券的授予、獎勵或其他獲取。</p>
<p>查看 Pediatrix Medical Group 內部交易的完整列表。</p>
<p><strong>內部購買警報：從 C-suite 的舉動中獲利</strong></p>
<p>Benzinga Edge 實時揭示每一筆內部交易。不要錯過下一個由內部信心驅動的大幅股票變動。立即解鎖這個終極情緒指標。點擊這裏獲取訪問權限。</p>
<p><em>本文由 Benzinga 的自動內容引擎生成，並由編輯審核。</em></p>

<p>根據 SEC 的 Form 4 文件，Pediatrix Medical Group 的首席執行官 Mark Ordan 出售了 23,000 股，價值 515,430 美元。此次內部交易於 12 月 17 日被報告。Pediatrix Medical Group 的股價下跌了 0.27%，至 22.5 美元。該公司提供醫生服務，面臨收入增長挑戰，最近出現了-3.58% 的下降。儘管如此，它仍保持着強勁的毛利率和每股收益，且其市盈率和市銷率顯示出潛在的低估</p>

<p>A substantial insider sell was reported on December 17, by <strong>MARK ORDAN</strong>, Chief Executive Officer at <strong>Pediatrix Medical Group</strong> (NYSE: MD), based on the recent SEC filing.</p>
<div class="lb-trans"><p>在 12 月 17 日，<strong>MARK ORDAN</strong>，<strong>Pediatrix Medical Group</strong>（紐約證券交易所代碼：MD）的首席執行官，報告了一筆大規模的內部出售，基於最近的 SEC 文件。</p>
</div><p><strong>What Happened:</strong> ORDAN's recent move involves selling 23,000 shares of <strong>Pediatrix Medical Group</strong>. This information is documented in a Form 4 filing with the U.S. Securities and Exchange Commission on Wednesday. The total value is $515,430.</p>
<div class="lb-trans"><p>** 發生了什麼：**ORDAN 最近的舉動涉及出售 23,000 股 <strong>Pediatrix Medical Group</strong> 的股票。這一信息在週三的美國證券交易委員會的 Form 4 文件中有記錄。總價值為 515,430 美元。</p>
</div><p>During Thursday's morning session, <strong>Pediatrix Medical Group</strong> shares down by 0.27%, currently priced at $22.5.</p>
<div class="lb-trans"><p>在週四的早盤交易中，<strong>Pediatrix Medical Group</strong> 的股票下跌了 0.27%，目前價格為 22.5 美元。</p>
</div><h3>Discovering Pediatrix Medical Group: A Closer Look</h3>
<div class="lb-trans"><h3>瞭解 Pediatrix Medical Group：更深入的觀察</h3>
</div><p>Pediatrix Medical Group Inc provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment which provides physician services including newborn, maternal-fetal, and other pediatric subspecialty care. It generates majority of the revenue through neonatology and other pediatric subspecialties.</p>
<div class="lb-trans"><p>Pediatrix Medical Group Inc 為醫院、重症監護室和其他醫療單位提供醫生服務。該公司提供的服務包括為孕婦提供母嬰護理、為早產兒提供重症監護、為患有心臟缺陷的嬰兒提供心臟病護理，以及在手術期間提供麻醉護理等。該公司僅在一個部門運營，提供包括新生兒、母胎和其他兒科專業護理的醫生服務。它的收入主要來自新生兒學和其他兒科專業。</p>
</div><h3>Financial Insights: Pediatrix Medical Group</h3>
<div class="lb-trans"><h3>財務洞察：Pediatrix Medical Group</h3>
</div><p><strong>Revenue Challenges:</strong> Pediatrix Medical Group's revenue growth over 3 months faced difficulties. As of 30 September, 2025, the company experienced a decline of approximately <strong>-3.58%</strong>. This indicates a decrease in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Health Care sector.</p>
<div class="lb-trans"><p><strong>收入挑戰：</strong> 截至 2025 年 9 月 30 日，Pediatrix Medical Group 的收入增長面臨困難。公司經歷了約 <strong>-3.58%</strong> 的下降。這表明其收入出現了下滑。與競爭對手相比，該公司的增長率低於醫療保健行業的平均水平。</p>
</div><p><strong>Analyzing Profitability Metrics:</strong></p>
<div class="lb-trans"><p><strong>分析盈利能力指標：</strong></p>
</div><ul>
<li>Gross Margin: The company excels with a remarkable gross margin of 28.48%, indicating superior cost efficiency and profitability compared to its industry peers.</li>
</ul>
<div class="lb-trans"><ul>
<li>毛利率：該公司的毛利率為 28.48%，在成本效率和盈利能力方面優於行業同行。</li>
</ul>
</div><ul>
<li>Earnings per Share (EPS): Pediatrix Medical Group's EPS outshines the industry average, indicating a strong bottom-line trend with a current EPS of 0.85.</li>
</ul>
<div class="lb-trans"><ul>
<li>每股收益（EPS）：Pediatrix Medical Group 的每股收益超出行業平均水平，當前每股收益為 0.85，顯示出強勁的盈利趨勢。</li>
</ul>
</div><p><strong>Debt Management:</strong> Pediatrix Medical Group's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of <strong>0.72</strong>.</p>
<div class="lb-trans"><p>** 債務管理：**Pediatrix Medical Group 的債務與股本比率低於行業標準，表明其財務結構穩健，比例為 <strong>0.72</strong>。</p>
</div><p><strong>Valuation Metrics:</strong></p>
<div class="lb-trans"><p><strong>估值指標：</strong></p>
</div><ul>
<li>Price to Earnings (P/E) Ratio: Pediatrix Medical Group's P/E ratio of 11.81 is below the industry average, suggesting the stock may be undervalued.</li>
</ul>
<div class="lb-trans"><ul>
<li>市盈率（P/E）：Pediatrix Medical Group 的市盈率為 11.81，低於行業平均水平，暗示該股票可能被低估。</li>
</ul>
</div><ul>
<li>Price to Sales (P/S) Ratio: The Price to Sales ratio is 1.0, which is lower than the industry average. This suggests a possible undervaluation based on sales performance.</li>
</ul>
<div class="lb-trans"><ul>
<li>市銷率（P/S）：市銷率為 1.0，低於行業平均水平。這表明基於銷售表現可能存在低估。</li>
</ul>
</div><ul>
<li>EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): Indicated by a lower-than-industry-average EV/EBITDA ratio of 8.01, the company suggests a potential undervaluation, which might be advantageous for value-focused investors.</li>
</ul>
<div class="lb-trans"><ul>
<li>企業價值/息税折舊攤銷前利潤（EV/EBITDA）分析：該公司的 EV/EBITDA 比率為 8.01，低於行業平均水平，暗示可能被低估，這對價值投資者可能是有利的。</li>
</ul>
</div><p><strong>Market Capitalization Analysis:</strong> Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.</p>
<div class="lb-trans"><p><strong>市值分析：</strong> 該公司的市值低於行業基準，反映出相對於同行的規模較小。這可能與增長預期或運營能力等因素有關。</p>
</div><p>Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</p>
<div class="lb-trans"><p>現在通過查爾斯·施瓦布在線免佣金交易股票，這是一個值得信賴的全面投資公司。</p>
</div><h3>Uncovering the Importance of Insider Activity</h3>
<div class="lb-trans"><h3>揭示內部活動的重要性</h3>
</div><p>Investors should view insider transactions as part of a multifaceted analysis and not rely solely on them for decision-making.</p>
<div class="lb-trans"><p>投資者應將內部交易視為多方面分析的一部分，而不是僅僅依賴於它們進行決策。</p>
</div><p>In legal terms, an &#34;insider&#34; refers to any officer, director, or beneficial owner of more than ten percent of a company's equity securities registered under Section 12 of the Securities Exchange Act of 1934. This can include executives in the c-suite and large hedge funds. These insiders are required to let the public know of their transactions via a Form 4 filing, which must be filed within two business days of the transaction.</p>
<div class="lb-trans"><p>在法律術語中，“內部人” 是指任何公司股權證券的官員、董事或持有超過 10% 權益的受益所有者，這些證券根據 1934 年證券交易法第 12 條註冊。這可以包括高管和大型對沖基金。這些內部人需要通過 Form 4 文件向公眾披露他們的交易，該文件必須在交易後的兩個工作日內提交。</p>
</div><p>When a company insider makes a new purchase, that is an indication that they expect the stock to rise.</p>
<div class="lb-trans"><p>當公司內部人進行新購買時，這表明他們預計股票將會上漲。</p>
</div><p>Insider sells, on the other hand, can be made for a variety of reasons, and may not necessarily mean that the seller thinks the stock will go down.</p>
<div class="lb-trans"><p>另一方面，內部出售可能出於多種原因，並不一定意味着賣方認為股票會下跌。</p>
</div><h3>Transaction Codes Worth Your Attention</h3>
<div class="lb-trans"><h3>值得關注的交易代碼</h3>
</div><p>Examining transactions, investors often concentrate on those unfolding in the open market, meticulously detailed in Table I of the Form 4 filing. A <strong>P</strong> in Box 3 denotes a purchase, while <strong>S</strong> signifies a sale. Transaction code <strong>C</strong> indicates the conversion of an option, and transaction code <strong>A</strong> denotes a grant, award, or other acquisition of securities from the company.</p>
<div class="lb-trans"><p>在審查交易時，投資者 通常集中於在公開市場上進行的交易，這些交易在 Form 4 文件的表格 I 中詳細列出。Box 3 中的 <strong>P</strong> 表示購買，而 <strong>S</strong> 表示出售。交易代碼 <strong>C</strong> 表示期權的轉換，交易代碼 <strong>A</strong> 表示從公司獲得的證券的授予、獎勵或其他獲取。</p>
</div><p>Check Out The Full List Of Pediatrix Medical Group's Insider Trades.</p>
<div class="lb-trans"><p>查看 Pediatrix Medical Group 內部交易的完整列表。</p>
</div><p><strong>Insider Buying Alert: Profit from C-Suite Moves</strong></p>
<div class="lb-trans"><p><strong>內部購買警報：從 C-suite 的舉動中獲利</strong></p>
</div><p>Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. Click here for access.</p>
<div class="lb-trans"><p>Benzinga Edge 實時揭示每一筆內部交易。不要錯過下一個由內部信心驅動的大幅股票變動。立即解鎖這個終極情緒指標。點擊這裏獲取訪問權限。</p>
</div><p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>
<div class="lb-trans"><p><em>本文由 Benzinga 的自動內容引擎生成，並由編輯審核。</em></p>
</div>

馬克·奧爾丹執行了賣出訂單：出售了價值 51.5 萬美元的 Pediatrix Medical Group 股票